A new RNA-based therapy aims to address one of cardiology’s most persistent challenges: the heart’s inability to regenerate after injury. After a heart attack, restoring blood flow is often only part of the battle. Even when blocked arteries are reopened, the heart is left with permanent damage because lost muscle cells do not grow back. [...]from SciTechDaily https://ift.tt/gfXMKa4
